Evidence map›Paper›PMID 39777458›Full record

ArticleHuman molecular genetics2025

Diminished DNA binding affinity of DMRT1 caused by heterozygous DM domain mutations is a cause of male infertility.

Tihana Marić, Helen Castillo-Madeen, Monika Logara Klarić, Antun Barišić, Lovro Trgovec-Greif, Mark W Murphy, Anna-Grete Juchnewitsch, Kristiina Lillepea, Avirup Dutta, Lucija Žunić and 17 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Tihana MarićScientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Šalata 2, Zagreb 10000, Croatia.
Helen Castillo-MadeenDivision of Genetics, ONPRC & Oregon Health & Science University, 505 N.W. 185th Avenue, Beaverton, OR, USA.
Monika Logara KlarićGenom Ltd., Ilica 190, Zagreb 10000, Croatia.
Antun BarišićDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102A, Zagreb 10000, Croatia.
Lovro Trgovec-GreifRuđer Bošković Institute, Bijenička Cesta 54, Zagreb 10000, Croatia.
Mark W MurphyDepartment of Genetics, Cell Biology, and Development, University of Minnesota, 321 Church St. SE, Minneapolis, MN, USA.
Anna-Grete JuchnewitschInstitute of Biomedicine and Translational Medicine, University of Tartu, Ravila tn 19, Tartu, Estonia.
Kristiina LillepeaInstitute of Biomedicine and Translational Medicine, University of Tartu, Ravila tn 19, Tartu, Estonia.
Avirup DuttaInstitute of Biomedicine and Translational Medicine, University of Tartu, Ravila tn 19, Tartu, Estonia.
Lucija ŽunićGenom Ltd., Ilica 190, Zagreb 10000, Croatia.
Alexandra M StendahlDivision of Genetics, ONPRC & Oregon Health & Science University, 505 N.W. 185th Avenue, Beaverton, OR, USA.
Margus PunabInstitute of Biomedicine and Translational Medicine, University of Tartu, Ravila tn 19, Tartu, Estonia.
Kristjan PommAndrology Clinic, Tartu University Hospital, Ludvig Puusepa 8, Tartu, Estonia.
Daniel M MendozaAndrology Department, Universitat Autònoma de Barcelona, Plaça Cívica, 08193 Bellaterra, Barcelona, Spain.
Alexandra M LopesUniversity of Porto, Praça de Gomes Teixeira, 4099-002 Porto, Portugal.
Ana Merkler ŠorgićUniversity Hospital Zagreb, Ulica Mije Kišpatića 12, Zagreb 10000, Croatia.
Oliver VugrekRuđer Bošković Institute, Bijenička Cesta 54, Zagreb 10000, Croatia.
Joao GonçalvesDepartamento de Genética Humana, INSA, Av. Padre Cruz, 1649-016 Lisbon, Portugal.
Kristian AlmstrupCopenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark.
Kenneth I AstonAndrology and IVF Laboratory, University of Utah School of Medicine, 675 Arapeen Dr 201 Suite 201, Salt Lake City, UT, USA.
Robert BelužićRuđer Bošković Institute, Bijenička Cesta 54, Zagreb 10000, Croatia.
Davor JežekScientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Šalata 2, Zagreb 10000, Croatia.
Branimir BertošaDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102A, Zagreb 10000, Croatia.
Maris LaanInstitute of Biomedicine and Translational Medicine, University of Tartu, Ravila tn 19, Tartu, Estonia.
Ana Katušić BojanacScientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Šalata 2, Zagreb 10000, Croatia.
Donald F ConradDivision of Genetics, ONPRC & Oregon Health & Science University, 505 N.W. 185th Avenue, Beaverton, OR, USA.
Maja BarbalićGenom Ltd., Ilica 190, Zagreb 10000, Croatia.ORCID 0000-0001-8914-1691

Funding

Project IIIP50HD096723 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI John C Schimenti · 2019 to 2026
$15.0M
GENOMICS OF SPERMATOGENIC IMPAIRMENTR01HD078641 · NICHD · WASHINGTON UNIVERSITY · PI Kenneth Ivan Aston, DONALD F. CONRAD · 2014 to 2026
$6.3M
Control of spermatogonial stem cell formationR01GM127379 · NIGMS · UNIVERSITY OF MINNESOTA · PI ZARKOWER, DAVID A. · 2019 to 2022
$1.3M
Estonian Research Council PRG1021NICHD NIH HHS P50 HD096723NICHD NIH HHS R01 HD078641NIGMS NIH HHS R01 GM127379Scientific Center of Excellence for Reproductive and Regenerative Medicine, Republic of CroatiaUS National Institutes of Health GM127379
6 · The paper itself

Abstract

The most severe form of male infertility is idiopathic non-obstructive azoospermia (NOA), a complete sperm absence in the ejaculate. We performed exome sequencing in the Croatian infertile brothers with NOA and found a variant in DMRT1 (Doublesex and mab-3 related transcription factor 1) gene that was further assessed by the EMSA assay and molecular dynamic simulations. We additionally screened for DMRT1 mutations in 1940 infertile men diagnosed with spermatogenic failure, 644 normozoospermic controls, and 105 females with primary ovarian insufficiency (POI) recruited to the GEnetics of Male INfertility Initiative (GEMINI) or Estonian Andrology (ESTAND) cohorts. DMRT1 p.Pro74Leu (chr9:g.842059C > T) variant was detected in infertile brothers in the highly conserved position within the DNA binding DM domain of the protein. EMSA assay showed reduced DNA binding of DMRT1P74L and molecular dynamic simulations showed differences in structural and dynamical properties between the wild type protein and DMRT1P74L. Plausible disease-causing DMRT1 variants were only identified in infertile men (13/1940; 0.67%), and none in 639 fertile controls. Burden testing showed an excess of rare deleterious DM domain mutations in the infertility cohort compared to gnomAD v.4.0 population-based controls (Fisher's exact test, p = 1.44 x 10-5). Three rare deleterious variants in DMRT1 were found in 104 cases of POI. The findings of this study strengthen the evidence of DMRT1 variants being a causal factor for male infertility and provide the distribution of likely pathogenic variants across the gene. This is also the first study to suggest that DMRT1 variants may also be linked to POI.

Indexed as

AzoospermiaInfertility, MaleTranscription FactorsAdultDNAExome SequencingFemaleGenetic Predisposition to DiseaseHeterozygoteHumansMaleMolecular Dynamics SimulationMutationPrimary Ovarian InsufficiencyProtein BindingProtein DomainsDMRT1 proteinDNATranscription FactorsDMRT1exome sequencinggeneticsinfertility

Identifiers

PMID39777458
PMCPMC11891871

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.